I D BIO has a total of 12 patent applications. Its first patent ever was published in 2014. It filed its patents most often in Republic of Korea, France and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are VIRTTU BIOLOG LTD, TECON BIOLOGICAL CO LTD and INST PASTEUR SHANGHAI CAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 6 | |
#2 | France | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Therapeutic chemical compounds | |
#6 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Choi Yeo Jeong | 5 |
#2 | Park Su Jin | 4 |
#3 | Yu Min-Ah | 3 |
#4 | Coutaz Bethsabée | 3 |
#5 | Park Su-Jin | 3 |
#6 | Min Ah Yu | 3 |
#7 | Young Il Kim | 3 |
#8 | Choi Yeo-Jeong | 3 |
#9 | Kim Young-Il | 2 |
#10 | Kim Se Mi | 2 |
Publication | Filing date | Title |
---|---|---|
KR20200005511A | Noble severe fever with thrombocytopenia syndrome viruses | |
FR3094225A1 | Alteromonadaceae extract and its cosmetic use | |
FR3094233A1 | Cosmetic composition comprising the strain Lactobacillus bulgaricus GLB 44 and its uses | |
KR20200100216A | Recombinant influenza virus to form protection against heterologous influenza viruses and gene delivery and therapeutic vaccine comprising the same | |
KR20200005165A | Noble severe fever with thrombocytopenia syndrome viruses | |
KR20190123934A | Noble severe fever with thrombocytopenia syndrome viruses | |
KR20180073067A | Recombinant influenza virus to form cross-protection against multiple subtypes h9 and h5 of influenza viruses and vaccine comprising the same | |
KR20150118400A | Novel virus vaccine to form cross-protection against multiple subtypes of influenza viruses |